Keytruda Approved in China for Esophageal Squamous Cell Carcinoma Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter Keytruda is now approved in China for three different types of cancer. Source: Devices & Diagnostics Letter You Might Also Like Sinopharm to Begin Phase 3 Trial of its COVID-19 Vaccine Candidate in Peru August 20, 2020 Fist Assist Devices Earns CE Mark for Vein Compression Device February 24, 2020 Trump Criticizes FDA Delay of Convalescent Plasma EUA August 20, 2020